Haemonetics | HAE - Net Income

Stock Price
61.19
Daily Change
0.52 0.86%
Monthly
-12.72%
Yearly
-2.90%
Q1 Forecast
59.29

Haemonetics reported $44.74M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Avanos Medical USD -1.4M 75.4M Sep/2025
Baxter International USD -1.13B 1.08B Dec/2025
Becton, Dickinson and Co. USD 382M 111M Dec/2025
Boston Scientific USD 672M 83M Dec/2025
Cerus USD -20.92M 17.98M Dec/2024
Cooper Companies USD 84.6M 13.7M Sep/2025
Fresenius EUR 344M 14M Sep/2025
Fresenius Medical Care EUR 274.8M 49.8M Sep/2025
Globus Medical USD 118.97M 83.88M Sep/2025
Haemonetics USD 44.74M 6.06M Dec/2025
Hologic USD 179.1M 8.2M Dec/2025
ICU Medical USD -15.73M 12.34M Dec/2025
Intuitive Surgical USD 794.8M 90.4M Dec/2025
Masimo USD -100.4M 151.7M Sep/2025
Medtronic USD 1.14B 231M Dec/2025
Merit Medical Systems USD 27.76M 4.83M Sep/2025
Neogen USD -15.92M 52.26M Sep/2025
OraSure Technologies USD -4.51M 3.89M Sep/2024
Quidel USD -733M 477.6M Sep/2025
ResMed USD 392.59M 44.06M Dec/2025
STAAR Surgical USD 8.88M 25.7M Sep/2025
Steris USD 192.9M 1000K Dec/2025
Stryker USD 849M 10M Dec/2025
Surmodics USD -11.54M 3.99M Sep/2024
Teleflex USD -408.89M 531.47M Sep/2025
Terumo JPY 32.65B 2.4B Dec/2025
Thermo Fisher Scientific USD 1.96B 348M Dec/2025
US Physical Therapy USD 13.14M 745K Sep/2025
Zimmer Biomet Holdings USD 139.3M 91.6M Dec/2025